Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Pharmadrug Inc C.PHRX

Alternate Symbol(s):  LMLLF

PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural... see more

CSE:PHRX - Post Discussion

Pharmadrug Inc > No bashing here
View:
Post by Losermachine on Oct 22, 2021 9:23am

No bashing here

This stock just rayped you slowly and fled......
Comment by SamRothstein on Oct 22, 2021 9:27am
You have had this nic for less than 3 months. And I prefer your previous nonsequitors.  
Comment by SoreazzySam on Oct 22, 2021 8:51pm
This post has been removed in accordance with Community Policy
Comment by Goldy63 on Oct 22, 2021 10:22pm
This post has been removed in accordance with Community Policy
Comment by SamRothstein on Oct 23, 2021 12:41pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities